JSC “Grindeks” announces that the company’s
Kirovs Lipmans, Chairman of the
Juris Hmelnickis in JSC “Grindeks” has previously taken several managerial positions – he was the Quality Director, Certification Officer and the Member of the Board. Since 2014 Juris Hmelnickis is the Chairman of the
Juris Hmelnickis has obtained a PhD in chemistry and a Master’s degree in economics from the
Juris Hmelnickis does not own JSC “Grindeks” shares.
Janis Romanovskis will continue his work in the
About JSC “Grindeks”
“Grindeks” is an international pharmaceutical company focused on research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The Group of “Grindeks” has four subsidiary companies in
“Grindeks” specializes in the heart and cardiovascular, CNS, anti-cancer and gastroenterological medication therapeutic groups. A range of products covers a combination of original products Mildronate® (meldonium*) and Ftorafur®, generics, food supplements and active pharmaceutical ingredients.
*Notice: meldonium is included in the list of substances prohibited in sport.
Further information:
Laila Klavina
Head of the
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
laila.klavina@grindeks.lv
www.grindeks.eu
© OMX, source